GeneDx Holdings Corp - Class A
Research GeneDx Holdings Corp - Class A (WGS) on Bullrun: market cap USD 2.60B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerWGS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 2.60B
- Financial periodQ2 2026
- RevenueUSD 114.44M
- Net income-USD 17.74M
- Free cash flow-USD 39.10M
- Gross margin68.4%
Valuation Snapshot
latest market cap is USD 2.60B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 427.54M | -USD 21.00M | USD 14.26M | 69.7% | -0.73 | USD 105.00M | USD 52.72M | USD 308.18M |
| FY2024 | USD 305.45M | -USD 52.30M | -USD 33.99M | 63.6% | -1.94 | USD 85.21M | USD 53.12M | USD 245.25M |
| FY2023 | USD 202.57M | -USD 175.80M | -USD 185.40M | 44.4% | -7.23 | USD 99.68M | USD 53.19M | USD 228.02M |
| FY2022 | USD 234.69M | -USD 548.98M | -USD 326.31M | -11.4% | -53.63 | USD 123.93M | USD 11.00M | USD 253.71M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.60B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 3.80B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.15B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 71.18M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 102.09M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.08B | n/a | n/a | n/a |
About GeneDx Holdings Corp - Class A
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GeneDx Holdings Corp - Class A's market cap?
GeneDx Holdings Corp - Class A's market capitalization is USD 2.60B.
What does GeneDx Holdings Corp - Class A do?
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.